was carried out to adjust for potential confounding between the two groups.
OBJECTIVES The recanalization of the coronary chronic total occlusion (CTO) is also not equal to the improved left ventricular function. The present study will analyze what factors are contributing to successful recanalization, the long term clinical outcomes and the effects on myocardial salvage.
METHODS The patients who underwent coronary angiography (CAG) from 2008 to 2013 were consecutively enrolled. The patients were divided into 3 groups, the total occlusion and stenosis groups (group 1); total occlusion myocardial perfusion group (group 2); CTO PCI group (group 3). In the group 1 comparison was made between total occlusion and high grade stenosis and the patients were followed for the major adverse cardiovascular events. In the group 2 patients were divided into total occlusion and stenosis. The SPECT summed rest score, CAG indices (Syntax score, total MPG and MPGÂArea), echocardiography indices (LVED and EF) were calculated. In the group 3, 559 CTO patients were divided into successful and unsuccessful recanalization. The MPG, Bridge Point, Retrograde MPG, LVED and EF were calculated.
RESULTS
In the group 1, 253 total occlusion and 629 stenosis were included. No difference in clinical characters was found between total occlusion and stenosis except Syntax score. The MACE was significantly higher in total occlusion than in stenosis (P<0.05). No difference in MACE among PCI, CABG and medicine treatments. In the group 2 there were 111 patients who underwent SPECT and CAG, of them 41 had total occlusion and 70 had stenosis. The total occlusion had significantly larger SRS, higher SYNTAX score, reduced total MPG and MPGÂArea, enlarged LVED and reduced EF (P<0.05). Stepwise multivariate analysis showed that the SRS were independently correlated with EF, total occlusion and sex. In the group 3, 559 CTO attempted PCI. The success rate was 67%.
Stepwise multivariate analysis showed age, unfavorite CTO and higher J-score predicted unsuccessful recanalization. After successful PCI there were 175 MPG2-3 and 99 MPG0-1. Low MPG accounted for 36% and had low Bridge Point, low Retrograde MPG and increased LVED (P<0.05). There were 190 Bridge Point 0-1 and 369 Bridge Point 2-3. Low Bridge Point accounted for 34%. After PSmatch we found that low Bridge Point were correlated with complex CTO, high J-score, Retrograde MPG, low EF and enlarged LVED (P<0.05) CONCLUSIONS Medication and CABG have similar clinical outcome irrespective of CTO or stenosis. But CTO PCI may have poor clinical outcome in comparison with stenosis. In CTO PCI the artery integrity damage is more than stenosis. The myocardial perfusion and left ventricular function are poor in the CTO patients. MPG, total MPG, Bridge Point, EF and LVED are useful predictors of myocardial recovery after successful recanalization. Age, complex CTO and J-Score are 3 main anatomic factors affecting recanalization. MPG and Bridge Point help predict viability after recanalization.
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Efficacy and safety of 6-month dual antiplatelet therapy for more than 75 year old patients having BUMA implantation Jieyun Liu, Zhenjun Wang, Wen Yang, Chenchen Li, Lei Qin The Kaifeng central Hospital OBJECTIVES 12-month dual antiplatelet therapy (DAPT) is recommended after implantation of drug-eluting stents (DESs) in patients with coronary heart disease. BUMA is a new drug-eluting stent with two different functional coating layers, and More than 75 year old patients have more complications like bleeding and gastrointestinal intolerance. The time is not clear for elderly patients with BUMA implantation.
METHODS We reviewed the data of 242 consecutive more than 75 year old patients who had BUMA implantation four years ago and completed 6-month DAPT. They were divided into two groups randomly: 6-month and 12-month DAPT groups. The efficacy (a composite incidence of cardiac death, myocardial infarction and target vessel revascularization) and safety (incidences of bleeding, gastrointestinal trouble and drug discontinuation) were compared with two groups.
RESULTS 242 patients included in the analysis, 118 were 6-month DAPT group, 124were 12-month DAPT group. The mean follow-up duration was 24AE1.8 months after BUMA implantation. The age, history of hypertension and stroke, BMI, SBP, DBP, high-density lipoprotein-cholesterol (HDL-C), triglycerides (TG), fasting blood glucose (FBG), estimated glomerular filtration rate (eGFR), at baseline did not differ significantly between the two groups. The rates of multivessel lesions, prior MI, hemoglobin A1C (HbA1c) and low-density lipoprotein cholesterol were no difference significantly in two groups. There was no significant difference in the overall composite incidence of cardiac death, myocardial infarction and target vessel revascularization in two groups at one years after PCI. The rates of bleeding (especially minor bleeding), gastrointestinal trouble, drug discontinuation and any blood transfusion were markedly lower in the 6-month DAPT group than 12-month DAPT group (2.54%vs4.84%;4.24% vs6.45%;5.09%vs8.06%;0.85%vs2.42%, P<0.05).
CONCLUSIONS 6-month DAPT may be more preferable to more than 75 year old patients who have undergone BUMA implantation, because of it's efficacy and safety.
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The importance of serial measurement of platelet aggregation in long-term dual antiplatelet therapy following drug eluting stent implantation Fang Chen Department of Cardiology, Beijing An Zhen Hospital, Capital Medical University and Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing OBJECTIVES Dual antiplatelet therapy (DAPT) and the response to clopidogrel are two pivotal issues impacting on the use of drugeluting stents (DESs). Consequently, we analyzed the combined influence of these factors to evaluate their long term effect in patients undergoing DES implantation.
METHODS Platelet aggregation was serially measured by light transmission aggregometry in all eligible patients during the course of treatment with DAPT, and the mean platelet aggregation level of each participant was calculated. Based on the duration of DAPT and the mean platelet aggregation level, all the enrolled patients were then divided into four groups. The primary endpoint was a composite of all-cause death, nonfatal myocardial infarction (MI), stent thrombosis, unexpected repeat revascularization, and stroke.
RESULTS
We analyzed 1,245 suitable patients in this study. These were divided into group A (12 month DAPT & low platelet aggregation level) with 204 subjects, group B (>12 month DAPT & high platelet aggregation level) with 419 subjects, group C (12 month DAPT & high platelet aggregation level) with 289 subjects, and group D (>12 month DAPT & low platelet aggregation level) with 333 subjects. Compared with all other groups, group D was associated with a decreased incidence of primary endpoints [HR 0.485, 95%CI (0.25-0.96); P ¼ 0.038]. When the Cox proportional hazards model was further tested with D group as the reference category within the same group, groups B and C were associated with increased incidence of primary endpoints [HR 2.26, 95%CI (1.10-4.68); P ¼ 0.0273] and [HR 2.31, 95%CI (1.03-5.18); P ¼ 0.0413]. Their respective multivariate Cox proportional hazards regressions confirmed these trends. 
